Abstract PD3-06: Updated results from DESTINY-breast01, a phase 2 trial of trastuzumab deruxtecan (T-DXd ) in HER2 positive metastatic breast cancer
暂无分享，去创建一个
Sung-Bae Kim | J. Baselga | E. Tokunaga | H. Iwata | Yeon-Hee Park | F. André | K. Tamura | S. Im | A. Yver | S. Modi | J. Sohn | J. Cortés | S. Hurvitz | C. Saura | I. Krop | J. Tsurutani | K. Aogi | K. Lee | Yoshinori Ito | C. Perrin | T. Yamashita | N. Denduluri | J. Shahidi | Caleb Lee | Yali Liu | Lin Zhang